drugset / Trial / NCT06531915

Comparison of Efficacy and Safety Between Ciprofol and Remimazolam During Fiberoptic Bronchoscopy

NCT06531915

Unknown 190 enrolled Anhui Provincial Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Both ciprofol and remimazolam have been found to be potential alternatives to propofol (a commonly used anesthesia) during fiberoptic bronchoscopy, while the efficacy and safety between ciprofol and remimazolam have not been reported. This study aims to compare the efficacy and safety between ciprofol and remimazolam in patients undergoing fiberoptic bronchoscopy.

Timeline

Start
2024-12-01
Primary completion
2024-12-30
Completion
2025-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.4 mg/kg Intravenous
Comparator Remimazolam Small molecule 0.1 mg/kg Intravenous

Indications

No indication recorded.